Anthem Biosciences Ltd
NSE: ANTHEM BSE: 544449
₹769.10
(1.46%)
Mon, 25 May 2026, 02:29 pm
Market Cap438.28B
PE Ratio73.54
Dividend0
Health Technology
Biotechnology
24.5KAnthem Biosciences Balance Sheet
| Particulars | 2021 | 2022 | 2023 |
|---|---|---|---|
| Interest expense on debt | -100.86M | -67.63M | -95.35M |
| Pretax equity in earnings | 0 | 0 | 0 |
| Equity in earnings | 0 | 0 | 0 |
| Total assets | 16.19B | 20.14B | 23.98B |
| Total current assets | 10.93B | 13.23B | 14.82B |
| Cash and short term investments | 6.18B | 8.36B | 6.43B |
| Cash & equivalents | 3.49B | 3.43B | 1.84B |
| Short term investments | 2.69B | 4.93B | 4.59B |
| Total receivables, net | 3.34B | 2.75B | 4.91B |
| Accounts receivable - trade, net | 3.26B | 2.74B | 4.90B |
| Other receivables | 74.79M | 13.05M | 4.36M |
| Total inventory | 600.50M | 1.33B | 2.24B |
| Other current assets, total | 790.42M | 776.03M | 1.20B |
| Total non-current assets | 5.26B | 6.91B | 9.17B |
| Long term investments | 100.22M | 118.42M | 182.26M |
| Note receivable - long term | 63.26M | 56.82M | 56.73M |
| Investments in unconsolidated subsidiaries | 0 | 0 | 0 |
| Other investments | 36.96M | 61.60M | 125.53M |
| Net property/plant/equipment | 4.82B | 6.34B | 8.38B |
| Gross property/plant/equipment | 8.44B | 10.54B | 13.32B |
| Deferred tax assets | 159.38M | 249.08M | 413.95M |
| Net intangible assets | 68.99M | 90.89M | 62.43M |
| Goodwill, net | 0 | 0 | 0 |
| Other intangibles, net | 68.99M | 90.89M | 62.43M |
| Other long term assets, total | 97.51M | 105.53M | 122.94M |
| Short term debt | 307.65M | 291.98M | 1.23B |
| Current portion of LT debt and capital leases | 11.72M | 3.22M | 16.85M |
| Short term debt excl. current portion of LT debt | 295.93M | 288.76M | 1.21B |
| Accounts payable | 648.41M | 719.41M | 1.01B |
| Income tax payable | 193.89M | 58.83M | 64.11M |
| Long term debt | 70.30M | 969.52M | 1.16B |
| Long term debt excl. lease liabilities | 58.98M | 961.88M | 1.12B |
| Total equity | 13.55B | 17.41B | 19.25B |
| Shareholders' equity | 13.55B | 17.41B | 19.25B |
| Common equity, total | 13.55B | 17.41B | 19.25B |
| Other common equity | 1.02B | 1.35B | 1.71B |
| Total debt | 377.95M | 1.26B | 2.39B |
| Net debt | -5.80B | -7.10B | -4.05B |
| Change in accounts receivable | -715.29M | 521.31M | -2.16B |
| Change in taxes payable | — | — | — |
| Change in accounts payable | -120.84M | 71.00M | 288.00M |
| Change in other assets/liabilities | -321.19M | -916.76M | 75.13M |
| Sale of fixed assets & businesses | 560.00K | 7.72M | 6.91M |
| Purchase/sale of investments, net | -637.06M | -2.26B | 274.08M |
| Sale/maturity of investments | 0 | 0 | 274.08M |
| Purchase of investments | -637.06M | -2.26B | 0 |
| Other investing cash flow items, total | -250.00K | -120.00K | -2.69M |
| Issuance/retirement of debt, net | -645.21M | 895.74M | 1.07B |
| Issuance/retirement of long term debt | 0 | 0 | 0 |
| Issuance/retirement of short term debt | -506.98M | -7.16M | 919.91M |
| Issuance/retirement of other debt | -138.23M | 902.90M | 154.70M |
| Total cash dividends paid | -10.00K | 0 | 0 |
| Other financing cash flow items, total | 77.84M | -189.15M | 80.16M |